• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by ATRenew Inc.

    11/20/24 6:07:28 AM ET
    $RERE
    Other Specialty Stores
    Consumer Discretionary
    Get the next $RERE alert in real time by email
    6-K 1 rere-6k-2024y-q3.htm 6-K 6-K

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 6-K

     

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

    THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of November 2024

     

    Commission File Number: 001-40486

     

     

    ATRenew Inc.

    (Registrant’s Name)

     

     

    12th Floor, No. 6 Building
    433 Songhu Road, Shanghai
    People’s Republic of China

    (Address of Principal Executive Offices)

     

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

    Form 20-F  Form 40-F 

     

     

     

     


     

    EXHIBIT INDEX

     

    Exhibit No.

     

    Description

    99.1

     

    ATRenew Inc. Reports Unaudited Third Quarter 2024 Financial Results

     

     

     


     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    ATRenew Inc.

     

    By:

    /s/ Chen Chen

    Name:

    Chen Chen

    Title:

    Chief Financial Officer

     

    Date: November 20, 2024

     

     


    Get the next $RERE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RERE

    DatePrice TargetRatingAnalyst
    More analyst ratings